Vivek Upadhya is an associate at Grant & Eisenhofer, focusing on complex pharmaceutical and medical device litigation, securities, appraisal, and whistleblower/qui tam litigation. Mr. Upadhya previously worked with G&E’s mass tort division, where he worked on multi-district litigation involving prescription drugs such as Xarelto and Zofran.
Mr. Upadhya is currently representing the State of Delaware in qui tam litigation involving an allegedly fraudulent scheme by retailers to avoid their gift card escheat obligations to Delaware. Mr. Upadhya was also involved in In re JPMorgan Chase & Co Securities Litigation (S.D.N.Y.), which resulted in a $150 million settlement.
Mr. Upadhya received his J.D. from Emory University School of Law, where he served as a managing editor for the Emory Law Journal. He received his B.A. in law and political science from the University of Utrecht in the Netherlands, and was born and raised in India.DOWNLOAD vCARD »